GlassScriptPhysician profile
Earl Cummings
NPI 1528121456
$1,118.30
in general payments reported to CMS, 2019-2025
17 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $860 · 2022: $28.21 · 2023: $82.72 · 2024: $22.76 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $397.66 | 2021-2025 | Wegovy, Saxenda |
| Astrazeneca Pharmaceuticals LP | $158.68 | 2021 | |
| Sanofi-Aventis U.S. LLC | $85.49 | 2021 | |
| Daiichi Sankyo INC. | $59.39 | 2021 | |
| Amarin Pharma, INC. | $57.11 | 2021 | |
| Eisai INC. | $49.61 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.29 | 2021 | |
| Amgen INC. | $44.81 | 2021 | |
| Abbott Laboratories | $41.45 | 2021-2024 | Eterna |
| Mylan Specialty L.P. | $33.33 | 2021 | |
| Abbvie INC. | $28.70 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $26.55 | 2021 | |
| Lilly USA, LLC | $23.80 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.96 | 2023 | Nuzyra |
| Esperion Therapeutics, INC. | $16.78 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.52 | 2021 | |
| Advanced Respiratory, INC | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.